Comprehensive coverage on anti-mycobacterial endeavour reported during 2022

TB being one of the deadliest diseases and second most common infectious cause of deaths, poses the severe threat to global health. The extended duration of therapy owing to resistance and its upsurge in immune-compromised patients have been the driving force for the development of novel of anti-TB...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of medicinal chemistry Vol. 255; p. 115409
Main Authors Dhameliya, Tejas M., Vekariya, Drashtiben D., Patel, Heta Y., Patel, Janvi T.
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 05.07.2023
Subjects
Anti-TB activity
Antitubercular Agents - chemistry
Heterocyclic scaffolds
Humans
M. tuberculosis
MDR-TB
Mycobacterium
Mycobacterium tuberculosis
Mycobacterium
MDR-TB
Heterocyclic scaffolds
Anti-TB activity
M. tuberculosis
Online AccessGet full text

Cover

Abstract TB being one of the deadliest diseases and second most common infectious cause of deaths, poses the severe threat to global health. The extended duration of therapy owing to resistance and its upsurge in immune-compromised patients have been the driving force for the development of novel of anti-TB scaffolds. Recently, we have compiled the account of anti-mycobacterial scaffolds published during 2015–2020 and updated them in 2021. The present work involves the insights on the anti-mycobacterial scaffolds reported in 2022 with their mechanism of action, structure activity relationships, along with the key perceptions for the design of newer anti-TB agents for the broader interests of medicinal chemists. [Display omitted] •Organized coverage of diversified scaffolds with anti-tubercular profile reported in 2022.•Novel heterocycles reported for anti-TB profile along with their merits and demerits.•Focused need for novel drug candidates against drug resistant strains.•Highlighted with mode of anti-TB action against M. tuberculosis strains.•Insightful discussion on their in silico, in vitro or in vivo anti-tuberculosis potential, if reported.
AbstractList TB being one of the deadliest diseases and second most common infectious cause of deaths, poses the severe threat to global health. The extended duration of therapy owing to resistance and its upsurge in immune-compromised patients have been the driving force for the development of novel of anti-TB scaffolds. Recently, we have compiled the account of anti-mycobacterial scaffolds published during 2015–2020 and updated them in 2021. The present work involves the insights on the anti-mycobacterial scaffolds reported in 2022 with their mechanism of action, structure activity relationships, along with the key perceptions for the design of newer anti-TB agents for the broader interests of medicinal chemists. [Display omitted] •Organized coverage of diversified scaffolds with anti-tubercular profile reported in 2022.•Novel heterocycles reported for anti-TB profile along with their merits and demerits.•Focused need for novel drug candidates against drug resistant strains.•Highlighted with mode of anti-TB action against M. tuberculosis strains.•Insightful discussion on their in silico, in vitro or in vivo anti-tuberculosis potential, if reported.
TB being one of the deadliest diseases and second most common infectious cause of deaths, poses the severe threat to global health. The extended duration of therapy owing to resistance and its upsurge in immune-compromised patients have been the driving force for the development of novel of anti-TB scaffolds. Recently, we have compiled the account of anti-mycobacterial scaffolds published during 2015-2020 and updated them in 2021. The present work involves the insights on the anti-mycobacterial scaffolds reported in 2022 with their mechanism of action, structure activity relationships, along with the key perceptions for the design of newer anti-TB agents for the broader interests of medicinal chemists.
ArticleNumber 115409
Author Dhameliya, Tejas M.
Vekariya, Drashtiben D.
Patel, Heta Y.
Patel, Janvi T.
Author_xml – sequence: 1
  givenname: Tejas M.
  orcidid: 0000-0001-5336-9918
  surname: Dhameliya
  fullname: Dhameliya, Tejas M.
  email: tejasm.dhameliya@nirmauni.ac.in, tmdhameliya@gmail.com
– sequence: 2
  givenname: Drashtiben D.
  surname: Vekariya
  fullname: Vekariya, Drashtiben D.
– sequence: 3
  givenname: Heta Y.
  surname: Patel
  fullname: Patel, Heta Y.
– sequence: 4
  givenname: Janvi T.
  surname: Patel
  fullname: Patel, Janvi T.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37120997$$D View this record in MEDLINE/PubMed
BookMark eNp9kD1v2zAQhokgQW0n_QdBobGL3OO3tRQojLQJaiBLMhMkdUpoWKRLSgb876NAacdOtzzvvXfPilzGFJGQWwprClR9269x36N_XTNgfE2pFNBckCXValNzJsUlWQJjvJaMiwVZlbIHAKkAPpEF15RB0-gl-b1N_THjK8YSTlj5dMJsX7BKsbJxCHV_9slZP2AO9lBhbNGe0pirjMeUB2yrdswhvlTTEeyGXHX2UPDzx7wmzz_vnrb39e7x18P2x672XLGhdtw516rGCfTKKie07Bx0FDUqycFKCkJZzmWnRAvWi0ayRjMNtNENaMWvydd57zGnPyOWwfSheDwcbMQ0FsM2sGFUbxRMqJhRn1MpGTtzzKG3-WwomHeNZm9mjeZdo5k1TrEvHw2j67H9F_rrbQK-zwBOf54CZlN8wOixDRn9YNoU_t_wBslqhe8
CitedBy_id crossref_primary_10_1002_slct_202302803
crossref_primary_10_1055_a_2201_7705
crossref_primary_10_3390_antibiotics13030212
crossref_primary_10_1055_s_0042_1751533
crossref_primary_10_1016_j_ejmech_2024_116268
crossref_primary_10_1002_slct_202303982
crossref_primary_10_1007_s11030_024_10842_8
Cites_doi 10.1016/j.ejmech.2022.114896
10.1111/jam.14478
10.1016/j.ijid.2022.02.043
10.4155/fmc-2022-0079
10.1016/j.ijid.2022.03.046
10.1016/j.ejmech.2022.114946
10.1056/NEJMoa1313865
10.1016/j.ejmech.2022.114908
10.1021/acs.jmedchem.2c00227
10.1016/j.molstruc.2021.131473
10.1002/slct.202201813
10.1021/acsmedchemlett.2c00401
10.1039/D1MD00367D
10.3390/molecules27092844
10.1039/D1NJ05171G
10.2174/1573406418666211116144952
10.1016/j.jorganchem.2022.122299
10.1039/D2RA03318F
10.1016/j.ejmech.2022.114639
10.1021/acs.jmedchem.2c00718
10.3390/app10072269
10.1016/j.molstruc.2022.133899
10.1016/j.bmcl.2022.128604
10.1021/acs.jcim.1c01390
10.1128/spectrum.02477-21
10.1016/j.bmcl.2022.128824
10.1016/j.bioorg.2022.106312
10.1021/acsmedchemlett.1c00652
10.1016/j.bioorg.2022.106125
10.4155/fmc-2022-0052
10.1002/med.21454
10.1021/acs.jmedchem.2c01064
10.1007/s11030-022-10500-x
10.1016/j.tet.2022.133231
10.1016/j.bmc.2022.116777
10.1021/acsmedchemlett.2c00254
10.1056/NEJMoa1201964
10.1021/acsinfecdis.1c00643
10.1016/j.bioorg.2022.105688
10.1016/j.ejmech.2022.114404
10.1021/acs.jmedchem.2c00352
10.1021/acsinfecdis.2c00433
10.1016/j.bioorg.2022.105869
10.1016/j.ejmech.2022.114698
10.4155/fmc-2021-0348
10.1016/j.ejmech.2022.114206
10.1002/jhet.4548
10.1016/j.bmc.2022.117006
10.1016/j.ejmech.2022.114145
10.1016/j.molstruc.2022.132336
10.1016/j.bmc.2022.117046
10.2174/0929867323666151106125759
10.1021/acs.jcim.2c00531
10.1016/j.molstruc.2022.134243
10.1016/j.bmc.2022.116938
10.1002/ardp.202200168
10.1002/slct.202200921
10.1021/acsmedchemlett.2c00215
10.1002/prot.26268
10.1016/j.ijid.2022.03.011
10.1021/acsinfecdis.2c00392
10.1016/j.bioorg.2022.105907
10.1016/j.ijid.2022.03.016
10.3390/molecules27248807
10.1021/acsmedchemlett.5b00324
10.3390/ph15080992
10.2174/0929867054546654
10.1007/s40265-019-01207-9
10.1016/j.bioorg.2022.106250
10.1039/D1MD00387A
10.1016/j.bioorg.2022.105809
10.1016/j.bmc.2022.116896
10.1002/jhet.4557
10.1016/j.bmcl.2022.129008
10.1016/j.molstruc.2022.133822
10.1016/j.bioorg.2022.105929
10.1016/j.ijid.2022.03.026
10.1016/j.jmgm.2022.108231
10.1002/cbdv.202200324
ContentType Journal Article
Copyright 2023 Elsevier Masson SAS
Copyright © 2023 Elsevier Masson SAS. All rights reserved.
Copyright_xml – notice: 2023 Elsevier Masson SAS
– notice: Copyright © 2023 Elsevier Masson SAS. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.ejmech.2023.115409
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1768-3254
EndPage 115409
ExternalDocumentID 10_1016_j_ejmech_2023_115409
37120997
S0223523423003756
Genre Journal Article
Review
GroupedDBID ---
--K
--M
.~1
0R~
1RT
1~.
1~5
4.4
457
4G.
5GY
5VS
7-5
71M
8P~
9JM
9JN
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARLI
AATCM
AAXUO
ABFRF
ABGSF
ABJNI
ABMAC
ABOCM
ABUDA
ABYKQ
ABZDS
ACDAQ
ACGFO
ACIUM
ACRLP
ADBBV
ADECG
ADEZE
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FLBIZ
FNPLU
FYGXN
G-Q
GBLVA
J1W
KOM
M2Y
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SCC
SDF
SDG
SES
SEW
SPC
SPCBC
SSK
SSP
SSU
SSZ
T5K
~G-
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
RIG
1B1
29G
53G
AAQXK
AAXKI
AAYOK
AAYXX
ABFNM
ABXDB
ACNNM
ADMUD
AGRDE
AHHHB
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
FGOYB
G-2
HMS
HMT
HVGLF
HZ~
IHE
R2-
SCB
SOC
SPT
WUQ
7X8
ID FETCH-LOGICAL-c362t-b3bbbd69b4ec6a6b475fb0f1e7e6530a51046a335f64d0ac49529727019790763
IEDL.DBID .~1
ISSN 0223-5234
IngestDate Sat Aug 17 04:09:06 EDT 2024
Thu Sep 12 20:02:21 EDT 2024
Tue Aug 27 13:48:41 EDT 2024
Fri Feb 23 02:36:30 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Mycobacterium
MDR-TB
Heterocyclic scaffolds
Anti-TB activity
M. tuberculosis
Language English
License Copyright © 2023 Elsevier Masson SAS. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c362t-b3bbbd69b4ec6a6b475fb0f1e7e6530a51046a335f64d0ac49529727019790763
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ORCID 0000-0001-5336-9918
PMID 37120997
PQID 2808217860
PQPubID 23479
PageCount 1
ParticipantIDs proquest_miscellaneous_2808217860
crossref_primary_10_1016_j_ejmech_2023_115409
pubmed_primary_37120997
elsevier_sciencedirect_doi_10_1016_j_ejmech_2023_115409
PublicationCentury 2000
PublicationDate 2023-07-05
PublicationDateYYYYMMDD 2023-07-05
PublicationDate_xml – month: 07
  year: 2023
  text: 2023-07-05
  day: 05
PublicationDecade 2020
PublicationPlace France
PublicationPlace_xml – name: France
PublicationTitle European journal of medicinal chemistry
PublicationTitleAlternate Eur J Med Chem
PublicationYear 2023
Publisher Elsevier Masson SAS
Publisher_xml – name: Elsevier Masson SAS
References Chengalroyen, Mason, Borsellini, Tassoni, Abrahams, Lynch, Ahn, Ambler, Young, Crowley, Olsen, Warner, Barry, Boshoff, Lamers, Mizrahi (bib46) 2022; 8
Kumar Sahoo, Maddipatla, Nageswara Rao Gajula, Naiyaz Ahmad, Kaul, Nanduri, Sonti, Dasgupta, Chopra, Madhavi Yaddanapudi (bib34) 2022; 64
Bhattarai, Hegde, Li, Prathipati, Stevens, Yang, Zhou, Pandya, Cunningham, Grissom, Roman Sotelo, Sowards, Calisto, Destache, Rocha-Sanchez, Gumbart, Zgurskaya, Jackson, North (bib84) 2023; 66
Lee, Lee, Carroll, Choi, Min, Song, Via, Goldfeder, Kang, Jin, Park, Kwak, Kim, Jeon, Jeong, Joh, Chen, Olivier, Shaw, Follmann, Song, Lee, Lee, Kim, Dartois, Park, Cho, Barry (bib12) 2012; 367
Hanwarinroj, Thongdee, Sukchit, Taveepanich, Kamsri, Punkvang, Ketrat, Saparpakorn, Hannongbua, Suttisintong, Kittakoop, Spencer, Mulholland, Pungpo (bib22) 2022; 115
Allaka, Basavoju, Madhu Rekha, Sriram, Rama Krishna (bib76) 2022
Georgey, Abdel (bib67) 2022; 124
Hanwarinroj, Hannongbua, Adrian, Spencer, Pungpo (bib19) 2022; 14
Keam (bib18) 2019; 79
Malhi, Jasinski, Kaur, Paul, Sharma (bib71) 2022; 126
Lu, Wang, Zhao, Zhang (bib11) 2022; 14
Cai, Zhang, Lun, Zhu, Xu, Yang, Tang, Bishai, Yu (bib37) 2022; 27
Faazil, Malik, Ahmed, Alsantali, Yedla, Alsharif, Shaikh, Kamal (bib39) 2022; 126
Thongdee, Hanwarinroj, Pakamwong, Kamsri, Punkvang, Leanpolchareanchai, Ketrat, Saparpakorn, Hannongbua, Ariyachaokun, Suttisintong, Sureram, Kittakoop, Hongmanee, Santanirand, V Mukamolova, Blood, Takebayashi, Spencer, Mulholland, Pungpo (bib21) 2022; 62
Saleh, Altıntaş, Filiciotto, Zorlu, Luque, Ülger, Döndaş, Altug (bib81) 2023; 131
Tahir, Tabassum, Javed, Ali, Ashfaq, Shahzad, Synthesis (bib68) 2022; 1254
Pissinate, Villela, Rodrigues-Junior, Giacobbo, Grams, Abbadi, Trindade, Roesler Nery, Bonan, Back, Campos, Basso, Santos, Machado (bib52) 2016; 7
Pakamwong, Thongdee, Kamsri, Phusi, Kamsri, Punkvang, Ketrat, Saparpakorn, Hannongbua, Ariyachaokun, Suttisintong, Sureram, Kittakoop, Hongmanee, Santanirand, Spencer, Mulholland, Pungpo (bib20) 2022; 62
Zhao, Gao, Li, Sheng, Cui, Wang, Fu, Gao, Lin, Zou, Jackson, Huang, Lu, Zhang (bib48) 2022; 65
Chitti, Van Calster, Cappoen, Nandikolla, Khetmalis, Cos, Kumar, Murugesan, Gowri Chandra Sekhar (bib60) 2022; 12
Nayyar, Jain (bib25) 2005; 12
(bib4) 2022
Mori, Stelitano, Griego, Chiarelli, Cazzaniga, Gelain, Pini, Camera, Canzano, Fumagalli, Scarpa, Cordiglieri, Rizzello, Villa, Meneghetti (bib83) 2022; 15
Kumar Sahoo, Naiyaz Ahmad, Kaul, Nanduri, Dasgupta, Chopra, Madhavi Yaddanapudi (bib55) 2022; 19
Trawally, Ipek, Kaya, Akdemir (bib64) 2022; 121
Kumar, Patel, Jain (bib26) 2018; 38
Cheng, Wang, Chen, Chen, Wang, Chen, Shen, Tian, Ye, Lu, Huang, Lu, Zhang (bib77) 2022; 73
Shinde, Inamdar, Shinde, Pawar, Kushwaha, Obakachi, Kajee, Chauhan, Karpoormath (bib61) 2023; 1273
Zhang, Lun, Wang, Cai, Yang, Tang, Bishai, Yu (bib65) 2022; 65
Shah, Verma, Shah, Kumar (bib24) 2022; 60
Finger, Kufa, Soukup, Castagnolo, Roh, Korabecny (bib40) 2023; 246
Fernandes, Thompson, Castagnolo, Denny, Dos Santos (bib7) 2022; 65
Singh, Dwivedi, Gaharwar, Meena, Rajamani, Prasad (bib10) 2020; 128
Petersen, Al-Abri, Chakaya, Goletti, Parolina, Wejse, Mucheleng’anga, Al Khalili, Yeboah-Manu, Chanda-Kapata, Nasiri, Lungu, Maeurer, Tiberi, Ntoumi, Battista-Migliori, Zumla (bib9) 2022; 124
Tiberi, Utjesanovic, Galvin, Centis, Ambrosio, Van Den Boom, Zumla, Migliori (bib6) 2022; 124
Kancharla, Birudaraju, Pal, Reddy, Reddy, Vagolu, Sriram, Bonige (bib59) 2022; 46
Lawer, Tyler, Hards, Keighley, Cheung, Kierek, Su, Matikonda, McInnes, Tyndall, Krause, Cook, Gamble (bib79) 2022; 13
Osei-Wusu, Otchere, Asare, Ntoumi, Zumla, Asante-Poku, Yeboah-Manu (bib2) 2022; 124
Li, Wang, Chen, Lin, Li, Lu, Huang (bib45) 2023; 131
Raghu, Pradeep Kumar, Yogesh Kumar, Prashanth, Alshahrani, Ahmad, Jain (bib29) 2022; 60
Nasiri, Zangiabadian, Arabpour, Amini, Khalili, Centis, Ambrosio, Denholm, Schaaf, Van Den Boom, Kurhasani, Dalcolmo, Al-abri, Silva, Mu, Seaworth, Pontali, Saderi, Tiberi, Zumla, Migliori, Sotgiu (bib17) 2022; 124
Songsiriritthigul, Suttisintong, Punkvang, Pungpo, Spencer (bib23) 2022; 3
Huang, Luo, Xu, Guo, Yang, Zhu, Shen, Chen, Tang, Li, Li, Wang, Franzblau, Ding (bib43) 2022; 71
Semenya, Touitou, Masci, Maringolo, Rogerio, Felipe, Santos, Gianibbi, Manetti, Castagnolo (bib47) 2022; 237
Richter, Seidel, Goddard, Eckhardt, Lehmann, Dörner, Siersleben, Sondermann, Mann, Patzer, Jäger, Reiling, Imming (bib75) 2022; 13
Dhameliya, Bhakhar, Gajjar, Patel, Devani, V Hirani (bib27) 2022; 1248
Wmemas, Abdelrahman, Almahl, Al-Warhi, Majrashi, Abdel-Aziz (bib56) 2022; 27
Lungu, Kasapo, Mihova, Chimzizi, Sikazwe, Banda, Adam, Chanda-kapata, Kapata, Zumla, Mwaba (bib1) 2022; 124
Vadim Makarov (bib13) 2020; 10
Bhakhar, V Vaghela, Varakala, Chudasma, Gajjar, Nagar, Sriram, Dhameliya (bib38) 2022; 7
Yao, Wang, Fu, Li, You, Li, Lu (bib14) 2022; 10
Sahoo, Ahmad, Kaul, Nanduri, Dasgupta, Chopra, Yaddanapudi (bib33) 2022; 13
Bouz, Šlechta, Jand’ourek, Konečná, Paterová, Bárta, Novák, Kučera, Dal, Fenaroli, Zemanová, Forbak, Korduláková, Pavliš, Kubíčková, Doležal, Zitko (bib82) 2023; 9
Le, Constant, Tranier, Nahoum, Guillet, Maveyraud, Daffé, Mourey, Verhaeghe, Marrakchi (bib72) 2022; 71
Mallea, Acuña, Klahn, Artigas, Pavan, Demarqui, Lemus, Jara, Toro (bib41) 2022; 964
Chakaya, Petersen, Nantanda, Mungai, Migliori, Amanullah, Lungu, Ntoumi, Kumarasamy, Maeurer, Zumla (bib3) 2022; 124
Panciera, Lence, Rodríguez, Gracia, Aínsa, Marco-Marín, Rubio, Duarte Correia, González-Bello (bib50) 2022; 232
Tapera, Kekeçmuhammed, Sahin, Krishna, Lherbet, Homberset, Chebaiki, Tønjum, Mourey, Zorlu, Durdagi, Sarıpınar (bib85) 2022; 1270
Jadhavar, Vaja, Dhameliya, Chakraborti (bib8) 2015; 22
Sahoo, Gajula, Ahmad, Kaul, Nanduri, Sonti, Dasgupta, Chopra, Yaddanapudi (bib54) 2022; 355
V Faria, Passos, da Costa, de Oliveira, da Cruz, Castelo-Branco, Lourenço, Murta, Junior, Bernardino, Bastos, Boechat (bib36) 2021; 18
Veena, Raghu, Yogesh Kumar, Pradeep Kumar, Alharti, Prashanth, Jeon (bib30) 2022; 1269
Dhivya, Pradeepa, Sarvesh (bib35) 2022; 14
Skenders, Kummik, Cirule, Leimane, Kurve (bib16) 2016; 41
Borsoi, Alice, Sperotto, Ramos, Abbadi, Macchi Hopf, Da Silva Dadda, Rambo, Madeira Silva, Paz, Pissinate, Muniz, Neves, Galina, González, Perelló, De Matos Czeczot, Leyser, De Oliveira, De Araújo Lock, De Araújo, Costa, Bizarro, Basso, Machado (bib51) 2022; 13
Pang, Green, Chandrika, Garzan, Punetha, Holbrook, Willby, Posey, Tsodikov, Garneau-Tsodikova (bib44) 2022; 242
Singh, Grzegorzewicz, Fienberg, Müller, Khonde, Sanz, Alfonso, Urones, Drewes, Bantscheff, Ghidelli-Disse, Ioerger, Angala, Liu, Lee, Sacchettini, Krieger, Jackson, Chibale, Ghorpade (bib49) 2022; 8
Abdelaziz, Othman, Abdel-Aziz, Badr, Eisa (bib73) 2022; 129
Kumar, Kumari, Bhattacherjee, Venugopal, Parwez, Siddiqi, Krishnan, Panda (bib80) 2022; 242
Zhao, Mei, Guo, Si, Ma, Li, Li, Song (bib70) 2022; 128
Zhou, Shao, Wang, Cheung, Wu, Yu, Hu, Cook, Gong, Lu (bib57) 2023; 245
Qin, Wang, Wang, Fu, Batt, Besra, Wu, Wang, Huang, Lu, Li (bib63) 2022; 231
Hegde, Aragaw, Cole, Jachak, Ragunathan, Sharma, Harikishore, Grüber, Dick, Aldrich (bib74) 2022; 74
Dhameliya, Devani, Patel, Shah (bib28) 2022; 7
Acharya, Bhavsar, Jethava, Rajani, Pithawala, Patel (bib31) 2022; 59
El-Shoukrofy, Atta, Fahmy, Sriram, Mahran, Labouta (bib62) 2023; 131
Shi, Wang, Stelitano, Wu, Shan, Wu, Wang, Chiarelli, Lu, Qiao (bib32) 2022; 13
Paz, Denise de Moura Sperotto, Ramos, Pissinate, da Silva Rodrigues Junior, Abbadi, Borsoi, Rambo, Corso Minotto, da Silva Dadda, Galina, Macchi Hopf, Muniz, Borges Martinelli, Roth, Madeira Silva, Perelló, de Matos Czeczot, Neves, Duarte, Leyser, Dias de Oliveira, Bizarro, Machado, Basso (bib53) 2023; 245
Fu, He, Fu, Xia, N’Go, Lou, Wu, Pan, Vincent (bib69) 2022; 69
Diacon, Pym, Grobusch, De Los Rios, Gotuzzo, Vasilyeva, Leimane, Andries, Bakare, De Marez, Haxaire-Theeuwes, Lounis, Meyvisch, De Paepe, Van Heeswijk, Dannemann (bib15) 2014; 371
Othman, Hamdi, Abdel-aziz, Elfeky (bib58) 2022; 124
Khetmalis, Chitti, Umarani Wunnava, Karan Kumar, Murali Krishna Kumar, Murugesan, Chandra Sekhar (bib42) 2022; 13
Raj, Selvam, Roy, Mani Tripathi, Kesharwani, Gopal, Varshney, Sundriyal (bib78) 2022; 76
Naestholt, Tiberi, Goletti, Wejse (bib5) 2022; 124
Bangalore, Pedapati, Pranathi, Batchu, Misra, Estharala, Sriram, Kantevari (bib66) 2022
Paz (10.1016/j.ejmech.2023.115409_bib53) 2023; 245
Semenya (10.1016/j.ejmech.2023.115409_bib47) 2022; 237
Naestholt (10.1016/j.ejmech.2023.115409_bib5) 2022; 124
Saleh (10.1016/j.ejmech.2023.115409_bib81) 2023; 131
Keam (10.1016/j.ejmech.2023.115409_bib18) 2019; 79
Veena (10.1016/j.ejmech.2023.115409_bib30) 2022; 1269
Wmemas (10.1016/j.ejmech.2023.115409_bib56) 2022; 27
Tiberi (10.1016/j.ejmech.2023.115409_bib6) 2022; 124
Shinde (10.1016/j.ejmech.2023.115409_bib61) 2023; 1273
Bhakhar (10.1016/j.ejmech.2023.115409_bib38) 2022; 7
Panciera (10.1016/j.ejmech.2023.115409_bib50) 2022; 232
Bangalore (10.1016/j.ejmech.2023.115409_bib66) 2022
Richter (10.1016/j.ejmech.2023.115409_bib75) 2022; 13
Lu (10.1016/j.ejmech.2023.115409_bib11) 2022; 14
Zhao (10.1016/j.ejmech.2023.115409_bib48) 2022; 65
Chengalroyen (10.1016/j.ejmech.2023.115409_bib46) 2022; 8
Diacon (10.1016/j.ejmech.2023.115409_bib15) 2014; 371
Nasiri (10.1016/j.ejmech.2023.115409_bib17) 2022; 124
Singh (10.1016/j.ejmech.2023.115409_bib10) 2020; 128
Lawer (10.1016/j.ejmech.2023.115409_bib79) 2022; 13
Dhivya (10.1016/j.ejmech.2023.115409_bib35) 2022; 14
Kumar (10.1016/j.ejmech.2023.115409_bib26) 2018; 38
Li (10.1016/j.ejmech.2023.115409_bib45) 2023; 131
Tahir (10.1016/j.ejmech.2023.115409_bib68) 2022; 1254
Tapera (10.1016/j.ejmech.2023.115409_bib85) 2022; 1270
Pakamwong (10.1016/j.ejmech.2023.115409_bib20) 2022; 62
Songsiriritthigul (10.1016/j.ejmech.2023.115409_bib23) 2022; 3
Cheng (10.1016/j.ejmech.2023.115409_bib77) 2022; 73
Lee (10.1016/j.ejmech.2023.115409_bib12) 2012; 367
Pissinate (10.1016/j.ejmech.2023.115409_bib52) 2016; 7
Kumar (10.1016/j.ejmech.2023.115409_bib80) 2022; 242
Skenders (10.1016/j.ejmech.2023.115409_bib16) 2016; 41
Petersen (10.1016/j.ejmech.2023.115409_bib9) 2022; 124
Kumar Sahoo (10.1016/j.ejmech.2023.115409_bib55) 2022; 19
Shah (10.1016/j.ejmech.2023.115409_bib24) 2022; 60
Finger (10.1016/j.ejmech.2023.115409_bib40) 2023; 246
Vadim Makarov (10.1016/j.ejmech.2023.115409_bib13) 2020; 10
El-Shoukrofy (10.1016/j.ejmech.2023.115409_bib62) 2023; 131
Nayyar (10.1016/j.ejmech.2023.115409_bib25) 2005; 12
Cai (10.1016/j.ejmech.2023.115409_bib37) 2022; 27
Acharya (10.1016/j.ejmech.2023.115409_bib31) 2022; 59
Dhameliya (10.1016/j.ejmech.2023.115409_bib28) 2022; 7
Le (10.1016/j.ejmech.2023.115409_bib72) 2022; 71
Raj (10.1016/j.ejmech.2023.115409_bib78) 2022; 76
Malhi (10.1016/j.ejmech.2023.115409_bib71) 2022; 126
V Faria (10.1016/j.ejmech.2023.115409_bib36) 2021; 18
Othman (10.1016/j.ejmech.2023.115409_bib58) 2022; 124
Osei-Wusu (10.1016/j.ejmech.2023.115409_bib2) 2022; 124
Fernandes (10.1016/j.ejmech.2023.115409_bib7) 2022; 65
Bhattarai (10.1016/j.ejmech.2023.115409_bib84) 2023; 66
Hanwarinroj (10.1016/j.ejmech.2023.115409_bib19) 2022; 14
Sahoo (10.1016/j.ejmech.2023.115409_bib54) 2022; 355
Khetmalis (10.1016/j.ejmech.2023.115409_bib42) 2022; 13
Zhou (10.1016/j.ejmech.2023.115409_bib57) 2023; 245
Chitti (10.1016/j.ejmech.2023.115409_bib60) 2022; 12
Chakaya (10.1016/j.ejmech.2023.115409_bib3) 2022; 124
Dhameliya (10.1016/j.ejmech.2023.115409_bib27) 2022; 1248
Shi (10.1016/j.ejmech.2023.115409_bib32) 2022; 13
Lungu (10.1016/j.ejmech.2023.115409_bib1) 2022; 124
Sahoo (10.1016/j.ejmech.2023.115409_bib33) 2022; 13
Zhao (10.1016/j.ejmech.2023.115409_bib70) 2022; 128
Trawally (10.1016/j.ejmech.2023.115409_bib64) 2022; 121
Thongdee (10.1016/j.ejmech.2023.115409_bib21) 2022; 62
Hanwarinroj (10.1016/j.ejmech.2023.115409_bib22) 2022; 115
Kancharla (10.1016/j.ejmech.2023.115409_bib59) 2022; 46
Hegde (10.1016/j.ejmech.2023.115409_bib74) 2022; 74
Yao (10.1016/j.ejmech.2023.115409_bib14) 2022; 10
Singh (10.1016/j.ejmech.2023.115409_bib49) 2022; 8
Raghu (10.1016/j.ejmech.2023.115409_bib29) 2022; 60
Kumar Sahoo (10.1016/j.ejmech.2023.115409_bib34) 2022; 64
Allaka (10.1016/j.ejmech.2023.115409_bib76) 2022
Pang (10.1016/j.ejmech.2023.115409_bib44) 2022; 242
Qin (10.1016/j.ejmech.2023.115409_bib63) 2022; 231
Fu (10.1016/j.ejmech.2023.115409_bib69) 2022; 69
Bouz (10.1016/j.ejmech.2023.115409_bib82) 2023; 9
Zhang (10.1016/j.ejmech.2023.115409_bib65) 2022; 65
Georgey (10.1016/j.ejmech.2023.115409_bib67) 2022; 124
Jadhavar (10.1016/j.ejmech.2023.115409_bib8) 2015; 22
Abdelaziz (10.1016/j.ejmech.2023.115409_bib73) 2022; 129
Borsoi (10.1016/j.ejmech.2023.115409_bib51) 2022; 13
Faazil (10.1016/j.ejmech.2023.115409_bib39) 2022; 126
Huang (10.1016/j.ejmech.2023.115409_bib43) 2022; 71
Mori (10.1016/j.ejmech.2023.115409_bib83) 2022; 15
Mallea (10.1016/j.ejmech.2023.115409_bib41) 2022; 964
References_xml – volume: 60
  year: 2022
  ident: bib29
  article-title: Design, synthesis and molecular docking studies of imidazole and benzimidazole linked ethionamide derivatives as inhibitors of InhA and antituberculosis agents
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Jain
– volume: 65
  start-page: 7489
  year: 2022
  end-page: 7531
  ident: bib7
  article-title: Tuberculosis drug discovery: challenges and new horizons
  publication-title: J. Med. Chem.
  contributor:
    fullname: Dos Santos
– volume: 121
  year: 2022
  ident: bib64
  article-title: Mandelic acid-based spirothiazolidinones targeting M. tuberculosis : synthesis, in vitro and in silico investigations
  publication-title: Bioorg. Chem.
  contributor:
    fullname: Akdemir
– volume: 126
  year: 2022
  ident: bib71
  article-title: Synthesis, characterization and antitubercular activities of heterocyclic selenosemicarbazones
  publication-title: Bioorg. Chem.
  contributor:
    fullname: Sharma
– volume: 3
  start-page: 898
  year: 2022
  end-page: 904
  ident: bib23
  article-title: Inhibition of
  publication-title: Proteins
  contributor:
    fullname: Spencer
– volume: 64
  year: 2022
  ident: bib34
  article-title: Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant
  publication-title: Bioorg. Med. Chem.
  contributor:
    fullname: Madhavi Yaddanapudi
– volume: 1273
  year: 2023
  ident: bib61
  article-title: Discovery of oxazoline-triazole based hybrid molecules as DNA gyrase inhibitors: a new class of potential anti-tubercular agents
  publication-title: J. Mol. Struct.
  contributor:
    fullname: Karpoormath
– volume: 73
  year: 2022
  ident: bib77
  article-title: Discovery of biphenyls bearing thiobarbiturate fragment by structure-based strategy as
  publication-title: Bioorg. Med. Chem.
  contributor:
    fullname: Zhang
– volume: 10
  year: 2022
  ident: bib14
  article-title: Sudapyridine (WX-081), a novel compound against
  publication-title: Microbiol. Spectr.
  contributor:
    fullname: Lu
– volume: 18
  start-page: 701
  year: 2021
  end-page: 709
  ident: bib36
  article-title: Novel 2-nitroimidazole and imidazooxazole derivatives and their activity against
  publication-title: Med. Chem.
  contributor:
    fullname: Boechat
– volume: 13
  start-page: 593
  year: 2022
  end-page: 598
  ident: bib32
  article-title: Development of 6-methanesulfonyl-8-nitrobenzothiazinone based antitubercular agents
  publication-title: ACS Med. Chem. Lett.
  contributor:
    fullname: Qiao
– volume: 124
  year: 2022
  ident: bib5
  article-title: Armed conflict and human displacement may lead to an increase in the burden of tuberculosis in Europe
  publication-title: Int. J. Infect. Dis.
  contributor:
    fullname: Wejse
– volume: 12
  start-page: 22385
  year: 2022
  end-page: 22401
  ident: bib60
  article-title: Design, synthesis and biological evaluation of benzo[
  publication-title: RSC Adv.
  contributor:
    fullname: Gowri Chandra Sekhar
– volume: 65
  start-page: 13240
  year: 2022
  end-page: 13252
  ident: bib65
  article-title: Structure-based optimization of coumestan derivatives as polyketide synthase 13-thioesterase (Pks13-TE) inhibitors with improved hERG profiles for
  publication-title: J. Med. Chem.
  contributor:
    fullname: Yu
– volume: 15
  start-page: 992
  year: 2022
  ident: bib83
  article-title: Synthesis and assessment of the in vitro and ex vivo activity of salicylate synthase (Mbti) inhibitors as new candidates for the treatment of mycobacterial infections
  publication-title: Pharmaceuticals
  contributor:
    fullname: Meneghetti
– volume: 237
  year: 2022
  ident: bib47
  article-title: Tapping into the antitubercular potential of 2,5-dimethylpyrroles : a structure-activity relationship interrogation
  publication-title: Eur. J. Med. Chem.
  contributor:
    fullname: Castagnolo
– volume: 124
  year: 2022
  ident: bib6
  article-title: Drug resistant TB – latest developments in epidemiology, diagnostics and management
  publication-title: Int. J. Infect. Dis.
  contributor:
    fullname: Migliori
– volume: 14
  start-page: 851
  year: 2022
  end-page: 866
  ident: bib35
  article-title: Synthesis and
  publication-title: Future Med. Chem.
  contributor:
    fullname: Sarvesh
– volume: 7
  year: 2022
  ident: bib28
  article-title: Comprehensive coverage on anti-mycobacterial endeavour reported in 2021
  publication-title: ChemistrySelect
  contributor:
    fullname: Shah
– volume: 1248
  year: 2022
  ident: bib27
  article-title: Recent advancements and developments in search of anti-tuberculosis agents: a quinquennial update and future directions
  publication-title: J. Mol. Struct.
  contributor:
    fullname: V Hirani
– volume: 27
  start-page: 8807
  year: 2022
  ident: bib56
  article-title: Development of novel isatin-tethered quinolines as anti-tubercular agents against multi and extensively drug-resistant Mycobacterium tuberculosis
  publication-title: Molecules
  contributor:
    fullname: Abdel-Aziz
– volume: 13
  start-page: 327
  year: 2022
  end-page: 342
  ident: bib42
  article-title: Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-
  publication-title: RSC Med. Chem.
  contributor:
    fullname: Chandra Sekhar
– volume: 124
  start-page: 90
  year: 2022
  end-page: 103
  ident: bib17
  article-title: Delamanid-containing regimens and multidrug-resistant tuberculosis : a systematic review and meta-analysis
  publication-title: Int. J. Infect. Dis.
  contributor:
    fullname: Sotgiu
– volume: 128
  start-page: 1547
  year: 2020
  end-page: 1567
  ident: bib10
  article-title: Recent updates on drug resistance in
  publication-title: J. Appl. Microbiol.
  contributor:
    fullname: Prasad
– volume: 76
  year: 2022
  ident: bib78
  article-title: Identification of a new and diverse set of
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Sundriyal
– volume: 242
  year: 2022
  ident: bib80
  article-title: Design, synthesis and biological evaluation of (quinazoline 4-yloxy)acetamide and (4-oxoquinazoline-3(4H)-yl)acetamide derivatives as inhibitors of
  publication-title: Eur. J. Med. Chem.
  contributor:
    fullname: Panda
– volume: 124
  year: 2022
  ident: bib58
  article-title: Novel 2-arylthiazolidin-4-one-thiazole hybrids with potent activity against
  publication-title: Bioorg. Chem.
  contributor:
    fullname: Elfeky
– volume: 128
  year: 2022
  ident: bib70
  article-title: Discovery of new riminophenazine analogues as antimycobacterial agents against drug-resistant
  publication-title: Bioorg. Chem.
  contributor:
    fullname: Song
– volume: 129
  year: 2022
  ident: bib73
  article-title: Novel diaryl ether derivatives as InhA inhibitors: design, synthesis and antimycobacterial activity
  publication-title: Bioorg. Chem.
  contributor:
    fullname: Eisa
– volume: 131
  year: 2023
  ident: bib45
  article-title: Design, synthesis and biological evaluation of alkynyl-containing maleimide derivatives for the treatment of drug-resistant tuberculosis
  publication-title: Bioorg. Chem.
  contributor:
    fullname: Huang
– volume: 124
  year: 2022
  ident: bib67
  article-title: Design, synthesis and anti-
  publication-title: Bioorg. Chem.
  contributor:
    fullname: Abdel
– volume: 131
  year: 2023
  ident: bib81
  article-title: Structural assessment of novel spiro-naphthalene-1,2’-[1,3,4]oxadiazol-4-ones prepared under batch and flow chemistry with a concise antifungal and anti(myco)bacterial activity
  publication-title: Tetrahedron
  contributor:
    fullname: Altug
– volume: 964
  year: 2022
  ident: bib41
  article-title: Cyrhetrenyl and cymantrenyl
  publication-title: J. Organomet. Chem.
  contributor:
    fullname: Toro
– volume: 124
  year: 2022
  ident: bib9
  article-title: Revamping and reshaping global tb control programs by advancing lessons learnt from the COVID-19 pandemic
  publication-title: Int. J. Infect. Dis.
  contributor:
    fullname: Zumla
– volume: 8
  start-page: 612
  year: 2022
  end-page: 625
  ident: bib46
  article-title: DNA-Dependent binding of nargenicin to DnaE1 inhibits replication in
  publication-title: ACS Infect. Dis.
  contributor:
    fullname: Mizrahi
– volume: 9
  start-page: 79
  year: 2023
  end-page: 96
  ident: bib82
  article-title: Hybridization approach toward novel antituberculars: design, synthesis, and biological evaluation of compounds combining pyrazinamide and 4-aminosalicylic acid
  publication-title: ACS Infect. Dis.
  contributor:
    fullname: Zitko
– volume: 246
  year: 2023
  ident: bib40
  article-title: Pyrimidine derivatives with antitubercular activity
  publication-title: Eur. J. Med. Chem.
  contributor:
    fullname: Korabecny
– volume: 10
  start-page: 2269
  year: 2020
  ident: bib13
  article-title: Development of macozinone for TB treatment : an update
  publication-title: Appl. Sci.
  contributor:
    fullname: Vadim Makarov
– volume: 71
  year: 2022
  ident: bib43
  article-title: Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Ding
– volume: 131
  year: 2023
  ident: bib62
  article-title: New tetrahydropyrimidine-1,2,3-triazole clubbed compounds: antitubercular activity and thymidine monophosphate kinase (TMPKmt) inhibition
  publication-title: Bioorg. Chem.
  contributor:
    fullname: Labouta
– volume: 242
  year: 2022
  ident: bib44
  article-title: Discovery of substituted benzyloxy-benzylamine inhibitors of acetyltransferase Eis and their anti-mycobacterial activity
  publication-title: Eur. J. Med. Chem.
  contributor:
    fullname: Garneau-Tsodikova
– volume: 355
  year: 2022
  ident: bib54
  article-title: Bioevaluation of quinoline-4-carbonyl derivatives of piperazinyl-benzothiazinones as promising antimycobacterial agents
  publication-title: Arch. Pharm.
  contributor:
    fullname: Yaddanapudi
– volume: 22
  start-page: 4379
  year: 2015
  end-page: 4397
  ident: bib8
  article-title: Oxazolidinones as anti-tubercular agents: discovery, development and future perspectives
  publication-title: Curr. Med. Chem.
  contributor:
    fullname: Chakraborti
– volume: 62
  start-page: 1680
  year: 2022
  end-page: 1690
  ident: bib20
  article-title: Identification of potent dna gyrase inhibitors active against
  publication-title: J. Chem. Inf. Model.
  contributor:
    fullname: Pungpo
– volume: 232
  year: 2022
  ident: bib50
  article-title: Discovery of 3
  publication-title: Eur. J. Med. Chem.
  contributor:
    fullname: González-Bello
– volume: 13
  start-page: 1337
  year: 2022
  end-page: 1344
  ident: bib51
  article-title: Antitubercular activity of novel 2-(quinoline-4-yloxy)acetamides with improved drug-like properties
  publication-title: ACS Med. Chem. Lett.
  contributor:
    fullname: Machado
– volume: 115
  year: 2022
  ident: bib22
  article-title: In silico design of novel quinazoline-based compounds as potential
  publication-title: J. Mol. Graph. Model.
  contributor:
    fullname: Pungpo
– volume: 46
  start-page: 2863
  year: 2022
  end-page: 2874
  ident: bib59
  article-title: Synthesis and biological evaluation of isatin oxime ether-tethered aryl 1
  publication-title: New J. Chem.
  contributor:
    fullname: Bonige
– volume: 1270
  year: 2022
  ident: bib85
  article-title: Synthesis, characterization, anti-tuberculosis activity and molecular modeling studies of thiourea derivatives bearing aminoguanidine moiety
  publication-title: J. Mol. Struct.
  contributor:
    fullname: Sarıpınar
– volume: 74
  year: 2022
  ident: bib74
  article-title: Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agents
  publication-title: Bioorg. Med. Chem.
  contributor:
    fullname: Aldrich
– volume: 59
  start-page: 2142
  year: 2022
  end-page: 2164
  ident: bib31
  article-title: Synthesis, characterization, biological evaluation, and computational study of benzimidazole hybrid thiosemicarbazide derivatives
  publication-title: J. Heterocycl. Chem.
  contributor:
    fullname: Patel
– volume: 71
  year: 2022
  ident: bib72
  article-title: Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis
  publication-title: Bioorg. Med. Chem.
  contributor:
    fullname: Marrakchi
– volume: 38
  start-page: 684
  year: 2018
  end-page: 740
  ident: bib26
  article-title: New structural classes of antituberculosis agents
  publication-title: Med. Res. Rev.
  contributor:
    fullname: Jain
– volume: 245
  year: 2023
  ident: bib57
  article-title: Discovery of 1-hydroxy-2-methylquinolin-4(1
  publication-title: Eur. J. Med. Chem.
  contributor:
    fullname: Lu
– year: 2022
  ident: bib4
  article-title: Global tuberculosis report
– volume: 7
  start-page: 235
  year: 2016
  end-page: 239
  ident: bib52
  article-title: 2-(Quinolin-4-yloxy)acetamides are active against drug-susceptible and drug-resistant
  publication-title: ACS Med. Chem. Lett.
  contributor:
    fullname: Machado
– volume: 41
  start-page: 1393
  year: 2016
  end-page: 1400
  ident: bib16
  article-title: Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
  publication-title: Eur. Respir. J.
  contributor:
    fullname: Kurve
– volume: 12
  start-page: 1873
  year: 2005
  end-page: 1886
  ident: bib25
  article-title: Recent advances in new structural classes of anti-tuberculosis agents
  publication-title: Curr. Med. Chem.
  contributor:
    fullname: Jain
– volume: 14
  start-page: 1149
  year: 2022
  end-page: 1165
  ident: bib11
  article-title: Recent advances in oxazolidinones as antituberculosis agents
  publication-title: Future Med. Chem.
  contributor:
    fullname: Zhang
– volume: 66
  start-page: 170
  year: 2023
  end-page: 187
  ident: bib84
  article-title: Structural determinants of indole-2-carboxamides: identification of lead acetamides with Pan antimycobacterial activity
  publication-title: J. Med. Chem.
  contributor:
    fullname: North
– volume: 7
  year: 2022
  ident: bib38
  article-title: Indole-2-carboxamides as new anti-mycobacterial agents: design, synthesis, biological evaluation and molecular modeling against mmpL3
  publication-title: ChemistrySelect
  contributor:
    fullname: Dhameliya
– volume: 69
  year: 2022
  ident: bib69
  article-title: Synthesis and evaluation of inhibitors of
  publication-title: Bioorg. Med. Chem.
  contributor:
    fullname: Vincent
– volume: 126
  year: 2022
  ident: bib39
  article-title: Novel linezolid-based oxazolidinones as potent anticandidiasis and antitubercular agents
  publication-title: Bioorg. Chem.
  contributor:
    fullname: Kamal
– volume: 124
  year: 2022
  ident: bib3
  article-title: The WHO global tuberculosis 2021 report – not so good news and turning the tide back to End TB
  publication-title: Int. J. Infect. Dis.
  contributor:
    fullname: Zumla
– volume: 14
  start-page: 717
  year: 2022
  end-page: 729
  ident: bib19
  article-title: Discovery of novel and potent InhA inhibitors by an in silico screening and pharmacokinetic prediction
  publication-title: Future Med. Chem.
  contributor:
    fullname: Pungpo
– volume: 62
  start-page: 6508
  year: 2022
  end-page: 6518
  ident: bib21
  article-title: Virtual screening identifies novel and potent inhibitors of
  publication-title: J. Chem. Inf. Model.
  contributor:
    fullname: Pungpo
– volume: 231
  year: 2022
  ident: bib63
  article-title: Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis
  publication-title: Eur. J. Med. Chem.
  contributor:
    fullname: Li
– volume: 60
  start-page: 183
  year: 2022
  end-page: 200
  ident: bib24
  article-title: Synthesis and antimycobacterial evaluation of pyrazinamide, benzimidazole and carboxamide derivatives
  publication-title: J. Heterocycl. Chem.
  contributor:
    fullname: Kumar
– volume: 65
  start-page: 10534
  year: 2022
  end-page: 10553
  ident: bib48
  article-title: Design, synthesis, and biological evaluation of pyrrole-2-carboxamide derivatives as mycobacterial membrane protein large 3 inhibitors for treating drug-resistant tuberculosis
  publication-title: J. Med. Chem.
  contributor:
    fullname: Zhang
– volume: 367
  start-page: 1508
  year: 2012
  end-page: 1518
  ident: bib12
  article-title: Linezolid for treatment of chronic extensively drug-resistant tuberculosis
  publication-title: N. Engl. J. Med.
  contributor:
    fullname: Barry
– volume: 124
  year: 2022
  ident: bib1
  article-title: A 10-year review of TB notifications and mortality trends using a joint point analysis in Zambia - a high TB burden country
  publication-title: Int. J. Infect. Dis.
  contributor:
    fullname: Mwaba
– volume: 1269
  year: 2022
  ident: bib30
  article-title: Design and synthesis of novel benzimidazole linked thiazole derivatives as promising inhibitors of drug-resistant tuberculosis
  publication-title: J. Mol. Struct.
  contributor:
    fullname: Jeon
– year: 2022
  ident: bib66
  article-title: Aryl-n-hexanamide linked enaminones of usnic acid as promising antimicrobial agents
  publication-title: Mol. Divers.
  contributor:
    fullname: Kantevari
– year: 2022
  ident: bib76
  article-title: Design and synthesis of novel quinazolinyl-bisspirooxindoles as potent anti-tubercular agents: an ultrasound-promoted methodology
  publication-title: Mol. Divers.
  contributor:
    fullname: Rama Krishna
– volume: 371
  start-page: 723
  year: 2014
  end-page: 732
  ident: bib15
  article-title: Multidrug-resistant tuberculosis and culture conversion with bedaquiline
  publication-title: N. Engl. J. Med.
  contributor:
    fullname: Dannemann
– volume: 8
  start-page: 2315
  year: 2022
  end-page: 2326
  ident: bib49
  article-title: 1,3-Diarylpyrazolyl-acylsulfonamides target HadAB/BC complex in
  publication-title: ACS Infect. Dis.
  contributor:
    fullname: Ghorpade
– volume: 13
  start-page: 585
  year: 2022
  end-page: 593
  ident: bib33
  article-title: Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant
  publication-title: RSC Med. Chem.
  contributor:
    fullname: Yaddanapudi
– volume: 19
  year: 2022
  ident: bib55
  article-title: Exploration of isoxazole-carboxylic acid methyl ester based 2-substituted quinoline derivatives as promising antitubercular agents
  publication-title: Chem. Biodivers.
  contributor:
    fullname: Madhavi Yaddanapudi
– volume: 13
  start-page: 1663
  year: 2022
  end-page: 1669
  ident: bib79
  article-title: Synthesis and biological evaluation of aurachin D analogues as inhibitors of
  publication-title: ACS Med. Chem. Lett.
  contributor:
    fullname: Gamble
– volume: 79
  start-page: 1797
  year: 2019
  end-page: 1803
  ident: bib18
  article-title: Pretomanid: first approval
  publication-title: Drugs
  contributor:
    fullname: Keam
– volume: 1254
  year: 2022
  ident: bib68
  article-title: kinetics, structure-activity relationship and in silico ADME studies of new diazenyl azo-phenol derivatives against urease, SARS-CoV-2 main protease (Mpro) and ribosomal protein S1 (RpsA) of
  publication-title: J. Mol. Struct.
  contributor:
    fullname: Synthesis
– volume: 27
  start-page: 2844
  year: 2022
  ident: bib37
  article-title: Design, synthesis and biological evaluation of
  publication-title: Molecules
  contributor:
    fullname: Yu
– volume: 245
  year: 2023
  ident: bib53
  article-title: Novel 4-aminoquinolines: synthesis, inhibition of the
  publication-title: Eur. J. Med. Chem.
  contributor:
    fullname: Basso
– volume: 13
  start-page: 1302
  year: 2022
  end-page: 1310
  ident: bib75
  article-title: BTZ-cerived benzisothiazolinones with in vitro activity against
  publication-title: ACS Med. Chem. Lett.
  contributor:
    fullname: Imming
– volume: 124
  year: 2022
  ident: bib2
  article-title: Relevance of genomic diversity of
  publication-title: Int. J. Infect. Dis.
  contributor:
    fullname: Yeboah-Manu
– volume: 124
  issue: 2022
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib9
  article-title: Revamping and reshaping global tb control programs by advancing lessons learnt from the COVID-19 pandemic
  publication-title: Int. J. Infect. Dis.
  contributor:
    fullname: Petersen
– volume: 245
  year: 2023
  ident: 10.1016/j.ejmech.2023.115409_bib57
  article-title: Discovery of 1-hydroxy-2-methylquinolin-4(1H)-one derivatives as new cytochrome bd oxidase inhibitors for tuberculosis therapy
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2022.114896
  contributor:
    fullname: Zhou
– volume: 128
  start-page: 1547
  year: 2020
  ident: 10.1016/j.ejmech.2023.115409_bib10
  article-title: Recent updates on drug resistance in Mycobacterium tuberculosis
  publication-title: J. Appl. Microbiol.
  doi: 10.1111/jam.14478
  contributor:
    fullname: Singh
– volume: 124
  start-page: 90
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib17
  article-title: Delamanid-containing regimens and multidrug-resistant tuberculosis : a systematic review and meta-analysis
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2022.02.043
  contributor:
    fullname: Nasiri
– volume: 14
  start-page: 1149
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib11
  article-title: Recent advances in oxazolidinones as antituberculosis agents
  publication-title: Future Med. Chem.
  doi: 10.4155/fmc-2022-0079
  contributor:
    fullname: Lu
– volume: 124
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib1
  article-title: A 10-year review of TB notifications and mortality trends using a joint point analysis in Zambia - a high TB burden country
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2022.03.046
  contributor:
    fullname: Lungu
– volume: 246
  year: 2023
  ident: 10.1016/j.ejmech.2023.115409_bib40
  article-title: Pyrimidine derivatives with antitubercular activity
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2022.114946
  contributor:
    fullname: Finger
– year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib66
  article-title: Aryl-n-hexanamide linked enaminones of usnic acid as promising antimicrobial agents
  publication-title: Mol. Divers.
  contributor:
    fullname: Bangalore
– volume: 371
  start-page: 723
  year: 2014
  ident: 10.1016/j.ejmech.2023.115409_bib15
  article-title: Multidrug-resistant tuberculosis and culture conversion with bedaquiline
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1313865
  contributor:
    fullname: Diacon
– volume: 245
  year: 2023
  ident: 10.1016/j.ejmech.2023.115409_bib53
  article-title: Novel 4-aminoquinolines: synthesis, inhibition of the Mycobacterium tuberculosis enoyl-acyl carrier protein reductase, antitubercular activity, SAR, and preclinical evaluation
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2022.114908
  contributor:
    fullname: Paz
– volume: 65
  start-page: 7489
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib7
  article-title: Tuberculosis drug discovery: challenges and new horizons
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.2c00227
  contributor:
    fullname: Fernandes
– volume: 1248
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib27
  article-title: Recent advancements and developments in search of anti-tuberculosis agents: a quinquennial update and future directions
  publication-title: J. Mol. Struct.
  doi: 10.1016/j.molstruc.2021.131473
  contributor:
    fullname: Dhameliya
– volume: 7
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib38
  article-title: Indole-2-carboxamides as new anti-mycobacterial agents: design, synthesis, biological evaluation and molecular modeling against mmpL3
  publication-title: ChemistrySelect
  doi: 10.1002/slct.202201813
  contributor:
    fullname: Bhakhar
– volume: 13
  start-page: 1663
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib79
  article-title: Synthesis and biological evaluation of aurachin D analogues as inhibitors of Mycobacterium tuberculosis cytochrome bd oxidase
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/acsmedchemlett.2c00401
  contributor:
    fullname: Lawer
– volume: 13
  start-page: 327
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib42
  article-title: Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-a]pyridine analogues
  publication-title: RSC Med. Chem.
  doi: 10.1039/D1MD00367D
  contributor:
    fullname: Khetmalis
– volume: 27
  start-page: 2844
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib37
  article-title: Design, synthesis and biological evaluation of N-phenylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis
  publication-title: Molecules
  doi: 10.3390/molecules27092844
  contributor:
    fullname: Cai
– volume: 46
  start-page: 2863
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib59
  article-title: Synthesis and biological evaluation of isatin oxime ether-tethered aryl 1H-1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis
  publication-title: New J. Chem.
  doi: 10.1039/D1NJ05171G
  contributor:
    fullname: Kancharla
– volume: 18
  start-page: 701
  year: 2021
  ident: 10.1016/j.ejmech.2023.115409_bib36
  article-title: Novel 2-nitroimidazole and imidazooxazole derivatives and their activity against Trypanosoma cruzi and Mycobacterium tuberculosis
  publication-title: Med. Chem.
  doi: 10.2174/1573406418666211116144952
  contributor:
    fullname: V Faria
– volume: 964
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib41
  article-title: Cyrhetrenyl and cymantrenyl N-acylhydrazone complexes based on isoniazid: synthesis, characterization, X-ray crystal structures and antitubercular activity evaluation
  publication-title: J. Organomet. Chem.
  doi: 10.1016/j.jorganchem.2022.122299
  contributor:
    fullname: Mallea
– volume: 12
  start-page: 22385
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib60
  article-title: Design, synthesis and biological evaluation of benzo[d]imidazo[2,1-b]thiazole and imidazo[2,1-b]thiazole carboxamide triazole derivatives as antimycobacterial agents
  publication-title: RSC Adv.
  doi: 10.1039/D2RA03318F
  contributor:
    fullname: Chitti
– volume: 124
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib5
  article-title: Armed conflict and human displacement may lead to an increase in the burden of tuberculosis in Europe
  publication-title: Int. J. Infect. Dis.
  contributor:
    fullname: Naestholt
– volume: 242
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib80
  article-title: Design, synthesis and biological evaluation of (quinazoline 4-yloxy)acetamide and (4-oxoquinazoline-3(4H)-yl)acetamide derivatives as inhibitors of Mycobacterium tuberculosis bd oxidase
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2022.114639
  contributor:
    fullname: Kumar
– volume: 65
  start-page: 10534
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib48
  article-title: Design, synthesis, and biological evaluation of pyrrole-2-carboxamide derivatives as mycobacterial membrane protein large 3 inhibitors for treating drug-resistant tuberculosis
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.2c00718
  contributor:
    fullname: Zhao
– volume: 10
  start-page: 2269
  year: 2020
  ident: 10.1016/j.ejmech.2023.115409_bib13
  article-title: Development of macozinone for TB treatment : an update
  publication-title: Appl. Sci.
  doi: 10.3390/app10072269
  contributor:
    fullname: Vadim Makarov
– volume: 1270
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib85
  article-title: Synthesis, characterization, anti-tuberculosis activity and molecular modeling studies of thiourea derivatives bearing aminoguanidine moiety
  publication-title: J. Mol. Struct.
  doi: 10.1016/j.molstruc.2022.133899
  contributor:
    fullname: Tapera
– volume: 60
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib29
  article-title: Design, synthesis and molecular docking studies of imidazole and benzimidazole linked ethionamide derivatives as inhibitors of InhA and antituberculosis agents
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2022.128604
  contributor:
    fullname: Raghu
– volume: 62
  start-page: 1680
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib20
  article-title: Identification of potent dna gyrase inhibitors active against Mycobacterium tuberculosis
  publication-title: J. Chem. Inf. Model.
  doi: 10.1021/acs.jcim.1c01390
  contributor:
    fullname: Pakamwong
– volume: 10
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib14
  article-title: Sudapyridine (WX-081), a novel compound against Mycobacterium tuberculosis
  publication-title: Microbiol. Spectr.
  doi: 10.1128/spectrum.02477-21
  contributor:
    fullname: Yao
– volume: 71
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib43
  article-title: Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2022.128824
  contributor:
    fullname: Huang
– volume: 131
  year: 2023
  ident: 10.1016/j.ejmech.2023.115409_bib62
  article-title: New tetrahydropyrimidine-1,2,3-triazole clubbed compounds: antitubercular activity and thymidine monophosphate kinase (TMPKmt) inhibition
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2022.106312
  contributor:
    fullname: El-Shoukrofy
– volume: 13
  start-page: 593
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib32
  article-title: Development of 6-methanesulfonyl-8-nitrobenzothiazinone based antitubercular agents
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/acsmedchemlett.1c00652
  contributor:
    fullname: Shi
– volume: 129
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib73
  article-title: Novel diaryl ether derivatives as InhA inhibitors: design, synthesis and antimycobacterial activity
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2022.106125
  contributor:
    fullname: Abdelaziz
– volume: 14
  start-page: 851
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib35
  article-title: Synthesis and in vitro studies for structure-based design of novel chalcones as antitubercular agents targeting InhA
  publication-title: Future Med. Chem.
  doi: 10.4155/fmc-2022-0052
  contributor:
    fullname: Dhivya
– volume: 38
  start-page: 684
  year: 2018
  ident: 10.1016/j.ejmech.2023.115409_bib26
  article-title: New structural classes of antituberculosis agents
  publication-title: Med. Res. Rev.
  doi: 10.1002/med.21454
  contributor:
    fullname: Kumar
– volume: 65
  start-page: 13240
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib65
  article-title: Structure-based optimization of coumestan derivatives as polyketide synthase 13-thioesterase (Pks13-TE) inhibitors with improved hERG profiles for Mycobacterium tuberculosis treatment
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.2c01064
  contributor:
    fullname: Zhang
– year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib76
  article-title: Design and synthesis of novel quinazolinyl-bisspirooxindoles as potent anti-tubercular agents: an ultrasound-promoted methodology
  publication-title: Mol. Divers.
  doi: 10.1007/s11030-022-10500-x
  contributor:
    fullname: Allaka
– volume: 131
  year: 2023
  ident: 10.1016/j.ejmech.2023.115409_bib81
  article-title: Structural assessment of novel spiro-naphthalene-1,2’-[1,3,4]oxadiazol-4-ones prepared under batch and flow chemistry with a concise antifungal and anti(myco)bacterial activity
  publication-title: Tetrahedron
  doi: 10.1016/j.tet.2022.133231
  contributor:
    fullname: Saleh
– volume: 64
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib34
  article-title: Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2022.116777
  contributor:
    fullname: Kumar Sahoo
– volume: 13
  start-page: 1337
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib51
  article-title: Antitubercular activity of novel 2-(quinoline-4-yloxy)acetamides with improved drug-like properties
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/acsmedchemlett.2c00254
  contributor:
    fullname: Borsoi
– volume: 367
  start-page: 1508
  year: 2012
  ident: 10.1016/j.ejmech.2023.115409_bib12
  article-title: Linezolid for treatment of chronic extensively drug-resistant tuberculosis
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1201964
  contributor:
    fullname: Lee
– volume: 8
  start-page: 612
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib46
  article-title: DNA-Dependent binding of nargenicin to DnaE1 inhibits replication in Mycobacterium tuberculosis
  publication-title: ACS Infect. Dis.
  doi: 10.1021/acsinfecdis.1c00643
  contributor:
    fullname: Chengalroyen
– volume: 121
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib64
  article-title: Mandelic acid-based spirothiazolidinones targeting M. tuberculosis : synthesis, in vitro and in silico investigations
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2022.105688
  contributor:
    fullname: Trawally
– volume: 237
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib47
  article-title: Tapping into the antitubercular potential of 2,5-dimethylpyrroles : a structure-activity relationship interrogation
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2022.114404
  contributor:
    fullname: Semenya
– volume: 66
  start-page: 170
  year: 2023
  ident: 10.1016/j.ejmech.2023.115409_bib84
  article-title: Structural determinants of indole-2-carboxamides: identification of lead acetamides with Pan antimycobacterial activity
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.2c00352
  contributor:
    fullname: Bhattarai
– volume: 9
  start-page: 79
  year: 2023
  ident: 10.1016/j.ejmech.2023.115409_bib82
  article-title: Hybridization approach toward novel antituberculars: design, synthesis, and biological evaluation of compounds combining pyrazinamide and 4-aminosalicylic acid
  publication-title: ACS Infect. Dis.
  doi: 10.1021/acsinfecdis.2c00433
  contributor:
    fullname: Bouz
– volume: 126
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib39
  article-title: Novel linezolid-based oxazolidinones as potent anticandidiasis and antitubercular agents
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2022.105869
  contributor:
    fullname: Faazil
– volume: 242
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib44
  article-title: Discovery of substituted benzyloxy-benzylamine inhibitors of acetyltransferase Eis and their anti-mycobacterial activity
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2022.114698
  contributor:
    fullname: Pang
– volume: 14
  start-page: 717
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib19
  article-title: Discovery of novel and potent InhA inhibitors by an in silico screening and pharmacokinetic prediction
  publication-title: Future Med. Chem.
  doi: 10.4155/fmc-2021-0348
  contributor:
    fullname: Hanwarinroj
– volume: 232
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib50
  article-title: Discovery of 3H-pyrrolo[2,3-c]quinolines with activity against Mycobacterium tuberculosis by allosteric inhibition of the glutamate-5-kinase enzyme
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2022.114206
  contributor:
    fullname: Panciera
– volume: 59
  start-page: 2142
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib31
  article-title: Synthesis, characterization, biological evaluation, and computational study of benzimidazole hybrid thiosemicarbazide derivatives
  publication-title: J. Heterocycl. Chem.
  doi: 10.1002/jhet.4548
  contributor:
    fullname: Acharya
– volume: 73
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib77
  article-title: Discovery of biphenyls bearing thiobarbiturate fragment by structure-based strategy as Mycobacterium tuberculosis protein tyrosine phosphatase B inhibitors
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2022.117006
  contributor:
    fullname: Cheng
– volume: 231
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib63
  article-title: Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2022.114145
  contributor:
    fullname: Qin
– volume: 1254
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib68
  article-title: kinetics, structure-activity relationship and in silico ADME studies of new diazenyl azo-phenol derivatives against urease, SARS-CoV-2 main protease (Mpro) and ribosomal protein S1 (RpsA) of Mycobacterium tuberculosis
  publication-title: J. Mol. Struct.
  doi: 10.1016/j.molstruc.2022.132336
  contributor:
    fullname: Tahir
– volume: 74
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib74
  article-title: Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agents
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2022.117046
  contributor:
    fullname: Hegde
– volume: 22
  start-page: 4379
  year: 2015
  ident: 10.1016/j.ejmech.2023.115409_bib8
  article-title: Oxazolidinones as anti-tubercular agents: discovery, development and future perspectives
  publication-title: Curr. Med. Chem.
  doi: 10.2174/0929867323666151106125759
  contributor:
    fullname: Jadhavar
– volume: 62
  start-page: 6508
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib21
  article-title: Virtual screening identifies novel and potent inhibitors of Mycobacterium tuberculosis PknB with antibacterial activity
  publication-title: J. Chem. Inf. Model.
  doi: 10.1021/acs.jcim.2c00531
  contributor:
    fullname: Thongdee
– volume: 1273
  year: 2023
  ident: 10.1016/j.ejmech.2023.115409_bib61
  article-title: Discovery of oxazoline-triazole based hybrid molecules as DNA gyrase inhibitors: a new class of potential anti-tubercular agents
  publication-title: J. Mol. Struct.
  doi: 10.1016/j.molstruc.2022.134243
  contributor:
    fullname: Shinde
– volume: 71
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib72
  article-title: Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2022.116938
  contributor:
    fullname: Le
– volume: 355
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib54
  article-title: Bioevaluation of quinoline-4-carbonyl derivatives of piperazinyl-benzothiazinones as promising antimycobacterial agents
  publication-title: Arch. Pharm.
  doi: 10.1002/ardp.202200168
  contributor:
    fullname: Sahoo
– volume: 7
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib28
  article-title: Comprehensive coverage on anti-mycobacterial endeavour reported in 2021
  publication-title: ChemistrySelect
  doi: 10.1002/slct.202200921
  contributor:
    fullname: Dhameliya
– volume: 13
  start-page: 1302
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib75
  article-title: BTZ-cerived benzisothiazolinones with in vitro activity against Mycobacterium tuberculosis
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/acsmedchemlett.2c00215
  contributor:
    fullname: Richter
– volume: 3
  start-page: 898
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib23
  article-title: Inhibition of Mycobacterium tuberculosis InhA by 3-nitropropanoic acid
  publication-title: Proteins
  doi: 10.1002/prot.26268
  contributor:
    fullname: Songsiriritthigul
– volume: 124
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib3
  article-title: The WHO global tuberculosis 2021 report – not so good news and turning the tide back to End TB
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2022.03.011
  contributor:
    fullname: Chakaya
– volume: 8
  start-page: 2315
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib49
  article-title: 1,3-Diarylpyrazolyl-acylsulfonamides target HadAB/BC complex in Mycobacterium tuberculosis
  publication-title: ACS Infect. Dis.
  doi: 10.1021/acsinfecdis.2c00392
  contributor:
    fullname: Singh
– volume: 126
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib71
  article-title: Synthesis, characterization and antitubercular activities of heterocyclic selenosemicarbazones
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2022.105907
  contributor:
    fullname: Malhi
– volume: 124
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib2
  article-title: Relevance of genomic diversity of Mycobacterium tuberculosis complex in Africa
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2022.03.016
  contributor:
    fullname: Osei-Wusu
– volume: 27
  start-page: 8807
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib56
  article-title: Development of novel isatin-tethered quinolines as anti-tubercular agents against multi and extensively drug-resistant Mycobacterium tuberculosis
  publication-title: Molecules
  doi: 10.3390/molecules27248807
  contributor:
    fullname: Wmemas
– volume: 7
  start-page: 235
  year: 2016
  ident: 10.1016/j.ejmech.2023.115409_bib52
  article-title: 2-(Quinolin-4-yloxy)acetamides are active against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/acsmedchemlett.5b00324
  contributor:
    fullname: Pissinate
– volume: 15
  start-page: 992
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib83
  article-title: Synthesis and assessment of the in vitro and ex vivo activity of salicylate synthase (Mbti) inhibitors as new candidates for the treatment of mycobacterial infections
  publication-title: Pharmaceuticals
  doi: 10.3390/ph15080992
  contributor:
    fullname: Mori
– volume: 12
  start-page: 1873
  year: 2005
  ident: 10.1016/j.ejmech.2023.115409_bib25
  article-title: Recent advances in new structural classes of anti-tuberculosis agents
  publication-title: Curr. Med. Chem.
  doi: 10.2174/0929867054546654
  contributor:
    fullname: Nayyar
– volume: 79
  start-page: 1797
  year: 2019
  ident: 10.1016/j.ejmech.2023.115409_bib18
  article-title: Pretomanid: first approval
  publication-title: Drugs
  doi: 10.1007/s40265-019-01207-9
  contributor:
    fullname: Keam
– volume: 131
  year: 2023
  ident: 10.1016/j.ejmech.2023.115409_bib45
  article-title: Design, synthesis and biological evaluation of alkynyl-containing maleimide derivatives for the treatment of drug-resistant tuberculosis
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2022.106250
  contributor:
    fullname: Li
– volume: 13
  start-page: 585
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib33
  article-title: Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy
  publication-title: RSC Med. Chem.
  doi: 10.1039/D1MD00387A
  contributor:
    fullname: Sahoo
– volume: 124
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib58
  article-title: Novel 2-arylthiazolidin-4-one-thiazole hybrids with potent activity against Mycobacterium tuberculosis
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2022.105809
  contributor:
    fullname: Othman
– volume: 69
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib69
  article-title: Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2022.116896
  contributor:
    fullname: Fu
– volume: 60
  start-page: 183
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib24
  article-title: Synthesis and antimycobacterial evaluation of pyrazinamide, benzimidazole and carboxamide derivatives
  publication-title: J. Heterocycl. Chem.
  doi: 10.1002/jhet.4557
  contributor:
    fullname: Shah
– volume: 76
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib78
  article-title: Identification of a new and diverse set of Mycobacterium tuberculosis uracil-DNA glycosylase (MtUng) inhibitors using structure-based virtual screening: experimental validation and molecular dynamics studies
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2022.129008
  contributor:
    fullname: Raj
– volume: 41
  start-page: 1393
  year: 2016
  ident: 10.1016/j.ejmech.2023.115409_bib16
  article-title: Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
  publication-title: Eur. Respir. J.
  contributor:
    fullname: Skenders
– volume: 1269
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib30
  article-title: Design and synthesis of novel benzimidazole linked thiazole derivatives as promising inhibitors of drug-resistant tuberculosis
  publication-title: J. Mol. Struct.
  doi: 10.1016/j.molstruc.2022.133822
  contributor:
    fullname: Veena
– volume: 128
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib70
  article-title: Discovery of new riminophenazine analogues as antimycobacterial agents against drug-resistant Mycobacterium tuberculosis
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2022.105929
  contributor:
    fullname: Zhao
– volume: 124
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib6
  article-title: Drug resistant TB – latest developments in epidemiology, diagnostics and management
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2022.03.026
  contributor:
    fullname: Tiberi
– volume: 115
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib22
  article-title: In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictions
  publication-title: J. Mol. Graph. Model.
  doi: 10.1016/j.jmgm.2022.108231
  contributor:
    fullname: Hanwarinroj
– volume: 19
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib55
  article-title: Exploration of isoxazole-carboxylic acid methyl ester based 2-substituted quinoline derivatives as promising antitubercular agents
  publication-title: Chem. Biodivers.
  doi: 10.1002/cbdv.202200324
  contributor:
    fullname: Kumar Sahoo
– volume: 124
  year: 2022
  ident: 10.1016/j.ejmech.2023.115409_bib67
  article-title: Design, synthesis and anti- Mycobacterium tuberculosis evaluation of new thiazolidin-4-one and thiazolo[3,2-a][1,3,5]triazine derivatives
  publication-title: Bioorg. Chem.
  contributor:
    fullname: Georgey
SSID ssj0005600
Score 2.4838192
SecondaryResourceType review_article
Snippet TB being one of the deadliest diseases and second most common infectious cause of deaths, poses the severe threat to global health. The extended duration of...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 115409
SubjectTerms Anti-TB activity
Antitubercular Agents - chemistry
Heterocyclic scaffolds
Humans
M. tuberculosis
MDR-TB
Mycobacterium
Mycobacterium tuberculosis
Title Comprehensive coverage on anti-mycobacterial endeavour reported during 2022
URI https://dx.doi.org/10.1016/j.ejmech.2023.115409
https://www.ncbi.nlm.nih.gov/pubmed/37120997
https://search.proquest.com/docview/2808217860
Volume 255
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwED9EH_RFdH7NLyKIT9alH0nbRxnKVBRBBd9Ckqa4gZ1sU9iLf7uXpHUKiuDjykrSu_Tud73f3QEc5qlmKqJJwOMQAxSWFkGWmyignGpDVSgjbQuFr2947yG5fGSPc9BtamEsrbK2_d6mO2tdX-nU0uy89PudO_Q-iB5sBzs3yNW23U7QGeGZPnn_QvPgvgwF_2yDrqQpn3McLzN4Ni4lEcUnti-NpSX-7J5-g5_ODZ2vwHKNH8mp3-IqzJmqBYvdZmxbC45ufTPq6TG5n9VWjY_JEbmdtamersGVNQUj8-QZ7ERbLicaFzKsCEq7HzxPNb7rrpczLmi_lMs3XJ34LIMpiK9wJPhY0To8nJ_dd3tBPVoh0OixJoGKlVIFz1ViNJdcJSkrFS1DkxrOYiqZTf3KOGYlTwoqNYZRUY5QBwFhiuE0jzdgvhpWZgsIQk6b6ozKApEkLZJcUVkqnZnQTszNZBuCRqLixXfQEA21bCC8BoTVgPAaaEPaiF18OwkCjfwfdx40WhIodJv5kJUZvo5FhHvE2CvjtA2bXn2fe4lTXz68_e91d2DJ_nIkXrYL85PRq9lDqDJR--4s7sPC6cVV7-YDhuHl9g
link.rule.ids 315,786,790,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwED90PuiL-O38jCA-WZe2abo-ylCmc2PgBnsLSZriBnaiU9h_76VpHYIi-NoPLr1r737X-90F4DyJdaQCyjwe-pigRHHqNRMTeJRTbajyZaBto3C3x9tDdj-KRkvQqnphLK2y9P3OpxfeujzSKLXZeBmPG48YfRA92Al2xUaufBlWUJbParByfddp9xZMD-46UfB6m3exqoOuoHmZybMpqhJBeGVH01hm4s8R6jcEWkSi2w1YLyEkuXar3IQlk2_BaqvauW0LLvpuHvX8kgwW7VVvl-SC9BeTqufb0LHe4NU8ORI70ZbOif6FTHOCCh97z3ONn3sxzhkF2p_l8gOlE1doMClxTY4EHyvYgeHtzaDV9srdFTyNQWvmqVAplfJEMaO55IrFUaZo5pvY8CikMrLVXxmGUcZZSqXGTCpIEO0gJowxo-bhLtTyaW72gSDqtNXOIEsRTNKUJYrKTOmm8e2muU1ZB6_SqHhxQzRExS6bCGcBYS0gnAXqEFdqF99eBoF-_o87zyorCVS6LX7I3Ezf30SAa8T0q8lpHfac-b7WEsaug_jg33JPYbU96D6Ih7te5xDW7JmC0xsdQW32-m6OEbnM1En5Zn4CgG7orA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comprehensive+coverage+on+anti-mycobacterial+endeavour+reported+during+2022&rft.jtitle=European+journal+of+medicinal+chemistry&rft.au=Dhameliya%2C+Tejas+M.&rft.au=Vekariya%2C+Drashtiben+D.&rft.au=Patel%2C+Heta+Y.&rft.au=Patel%2C+Janvi+T.&rft.date=2023-07-05&rft.issn=0223-5234&rft.volume=255&rft.spage=115409&rft_id=info:doi/10.1016%2Fj.ejmech.2023.115409&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ejmech_2023_115409
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0223-5234&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0223-5234&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0223-5234&client=summon